Institute of Medical Psychology & Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, D-45147 Essen, Germany.
Institute of Medical Psychology & Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, D-45147 Essen, Germany; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, D-45147 Essen, Germany.
Brain Behav Immun. 2015 Aug;48:222-31. doi: 10.1016/j.bbi.2015.03.017. Epub 2015 Apr 14.
BACKGROUND & AIMS: To elucidate the brain mechanisms underlying inflammation-induced visceral hyperalgesia in humans, in this functional magnetic resonance imaging (fMRI) study we tested if intravenous administration of lipopolysaccharide (LPS) involves altered central processing of visceral pain stimuli.
In this randomized, double-blind, placebo-controlled fMRI study, 26 healthy male subjects received either an intravenous injection of low-dose LPS (N=14, 0.4 ng/kg body weight) or placebo (N=12, control group). Plasma cytokines (TNF-α, IL-6), body temperature, plasma cortisol and mood were assessed at baseline and up to 6 h post-injection. At baseline and 2 h post-injection (test), rectal pain thresholds and painful rectal distension-induced blood oxygen level-dependent (BOLD) responses in brain regions-of-interest were assessed. To address specificity for visceral pain, BOLD responses to non-painful rectal distensions and painful somatic stimuli (i.e., punctuate mechanical stimulation) were also analyzed as control stimuli.
Compared to the control group, LPS-treated subjects demonstrated significant and transient increases in TNF-α, IL-6, body temperature and cortisol, along with impaired mood. In response to LPS, rectal pain thresholds decreased in trend, along with enhanced up-regulation of rectal pain-induced BOLD responses within the posterior insula, dorsolateral prefrontal (DLPFC), anterior midcingulate (aMCC) and somatosensory cortices (all FWE-corrected p<0.05). Within the LPS group, more pronounced cytokine responses correlated significantly with enhanced rectal pain-induced neural activation in DLPFC and aMCC. No significant LPS effects were observed on neural responses to non-painful rectal distensions or mechanical stimulation.
These findings support that peripheral inflammatory processes affect visceral pain thresholds and the central processing of sensory-discriminative aspects of visceral pain.
为了阐明人类炎症引起内脏痛觉过敏的大脑机制,在这项功能磁共振成像(fMRI)研究中,我们测试了静脉内给予脂多糖(LPS)是否涉及内脏痛觉刺激的中枢处理改变。
在这项随机、双盲、安慰剂对照的 fMRI 研究中,26 名健康男性受试者分别接受静脉注射低剂量 LPS(N=14,0.4ng/kg 体重)或安慰剂(N=12,对照组)。在基线和注射后 6 小时评估血浆细胞因子(TNF-α、IL-6)、体温、血浆皮质醇和情绪。在基线和注射后 2 小时(测试)评估直肠痛觉阈值和感兴趣脑区的疼痛性直肠扩张诱导的血氧水平依赖(BOLD)反应。为了确定对内脏疼痛的特异性,还分析了非疼痛性直肠扩张和疼痛性躯体刺激(即点状机械刺激)的 BOLD 反应作为对照刺激。
与对照组相比,LPS 处理组的 TNF-α、IL-6、体温和皮质醇显著且短暂升高,情绪受损。LPS 处理后直肠痛觉阈值呈下降趋势,后岛、背外侧前额叶(DLPFC)、前扣带(aMCC)和躯体感觉皮质中直肠痛诱导的 BOLD 反应增强(所有 FWE 校正 p<0.05)。在 LPS 组中,更强的细胞因子反应与 DLPFC 和 aMCC 中直肠痛诱导的神经激活显著相关。未观察到 LPS 对非疼痛性直肠扩张或机械刺激的神经反应有显著影响。
这些发现支持外周炎症过程影响内脏痛觉阈值和内脏痛觉的感觉辨别中枢处理。